Dunvegan Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TTM
Tata Motors Limited
TTM
|
+$1.06M |
| 2 |
Emerson Electric
EMR
|
+$765K |
| 3 |
Chevron
CVX
|
+$205K |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$112K |
| 5 |
Becton Dickinson
BDX
|
+$66.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$1.07M |
| 2 |
TC Energy
TRP
|
+$877K |
| 3 |
Devon Energy
DVN
|
+$540K |
| 4 |
Dominion Energy
D
|
+$480K |
| 5 |
Alerian MLP ETF
AMLP
|
+$367K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.81% |
| 2 | Financials | 18.27% |
| 3 | Healthcare | 16.04% |
| 4 | Consumer Staples | 13.36% |
| 5 | Energy | 11.65% |
Similar funds
Dunvegan Associates's Q4 2015 Portfolio in Review
As of Q4 2015, Dunvegan Associates held 212 positions worth $85.1M, down 3% from $87.7M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Dunvegan Associates withdrew a net $3.87M in Q4 2015, closing 8 positions and reducing 63 holdings. Its most notable exit was VelocityShares Daily Inverse VIX Short Term ETN, an estimated $32K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Dunvegan Associates opened a new position in Tata Motors Limited worth $1.08M.
- Dunvegan Associates's largest Q4 2015 buy was Tata Motors Limited: 36,512 shares worth $1.08M.
- Dunvegan Associates added most to Emerson Electric in Q4 2015, an estimated $765K increase.
- Dunvegan Associates's biggest Q4 2015 reduction was Enbridge, cutting an estimated $1.07M.
- Dunvegan Associates fully exited VelocityShares Daily Inverse VIX Short Term ETN in Q4 2015, selling an estimated $32K.
- Dunvegan Associates's ten largest holdings make up 52% of its $85.1M portfolio in Q4 2015.
- Dunvegan Associates opened 3 new positions and closed 8 in Q4 2015.
- Dunvegan Associates's portfolio value fell 3% quarter-over-quarter to $85.1M.
Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.